China Biologic Products Announces 2009 First Quarter Results Conference Call

TAI'AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"),
one of the leading plasma-based pharmaceutical companies in the People's
Republic of China ("PRC"), today announced that it will host a conference call
at 8:00 a.m. EDT on Tuesday, May 19, 2009, to discuss the 2009 first quarter
financial results.
Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr.
Tristan Kuo, Chief Financial Officer.
To participate in the live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call time: 888-
419-5570. International callers should dial 617-896-9871. The pass code for
the call is 634 701 69.
If you are unable to participate in the call at this time, a replay will
be available for 14 days starting on Tuesday, May 19, 2009 at 10:00 a.m. EDT.
To access the replay, dial 888-286-8010, international callers should dial
617-801-6888. The conference pass code is 373 105 74.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the "Company"), through its indirect
majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., and
equity investments in Xi'an Huitian Blood Products Co., Ltd. and Chongqing
Dalin Biologic Technologies Co., Ltd. is currently the largest non-state-owned
plasma-based biopharmaceutical company approved by the Chinese government. The
Company is a fully integrated biologic products company with plasma
collection,
production and manufacturing, research and development, and commercial
operations. The Company's blood products are irreplaceable in the application
of medical emergencies, and prevention and treatment for various diseases. It
sells its plasma-based biopharmaceutical products to hospitals and other
healthcare facilities in China.
For more information, please contact:

Company Contact:
Mr. Y. Tristan Kuo
CFO
China Biologic Products, Inc.
Tel: +86-538-6202206
Email: IR@chinabiologic.com
Web: http://www.chinabiologic.com

Investor Relations Contact:
Mr. Crocker Coulson, President
CCG Investor Relations
Tel: +1-646-213-1915 (NY office), or
Mr. Gary Chin
Tel: +1-646-213-1909
Email: crocker.coulson@ccgir.com
Web: http://www.ccgirasia.com

SOURCE China Biologic Products, Inc.

Company Contact: Mr. Y. Tristan Kuo, CFO of China Biologic Products, Inc.,
+86-538-6202206, or IR@chinabiologic.com; Or Investor Relations Contact: Mr.
Crocker Coulson, President of CCG Investor Relations, +1-646-213-1915 (NY
office), or Mr. Gary Chin, +1-646-213-1909, or crocker.coulson@ccgir.com